| Literature DB >> 30538765 |
Nan Xiao1,2, Hao Chen2, Shi-Yong He2, Chong-Xiang Xue2, Hua Sui2, Jing Chen2, Jia-Lin Qu1, Li-Na Liang2, Lin Zhang2.
Abstract
Objective. In China, the method of clearing heat and removing dampness medicine of Chinese traditional medicine has been widely used on gout. However, the clinical effects are various and not summarized systematically. Methods. In this study, a large number of randomized controlled clinical trials were reviewed and analyzed and the clinical efficacy and adverse reactions of traditional Chinese medicine with clearing heat and removing dampness effects for the treatment of gout were systematically evaluated. A comprehensive search of databases including pubMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database, Wanfang Data, and SinoMed was performed. Results. There are 69 randomized controlled trials with 5915 sample sizes meeting the criteria in the study. The results of the meta-analysis indicate that the effects of clearing heat and removing dampness medicine were slightly better than western medicine in the treatment of gout based on the following parameters: serum uric acid (standardized mean difference (SMD):-62.14, 95% confidence interval (CI): -78.12 to-46.15), C reactive protein (SMD: -4.21, 95% CI: -6.19 to -2.23), erythrocyte sedimentation rate (SMD: -6.23, 95% CI: -8.39 to-4.06), and overall clinical response (relative risk (RR): 1.11, 95% CI: 1.08 to 1.15) and, in the profile of adverse drug reactions, the clearing heat and removing dampness medicine showed less adverse reactions than traditional Western medicine (RR: 0.18, 95% CI: 0.10 to 0.32). Conclusions. Through a systemic evaluation of the clinical efficacy of the clearing heat and removing dampness medicine of traditional Chinese medicine and western medicine on gout, the clearing heat and removing dampness medicine and western medicine possessed similar clinical efficacy, but traditional Chinese medicine treatments are superior to western medicine in controlling adverse reactions.Entities:
Year: 2018 PMID: 30538765 PMCID: PMC6260541 DOI: 10.1155/2018/8591349
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram of study selection.
Characteristics of included studies.
| Author, year | Sample size | Age | Intervention methods | Duration treatment | Effective number | Jadad scale | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EG | CG | EG | CG | EG | CG | EG | CG | EG | CG | ||
| Yan Zhang, | 27 | 25 | 47.04±12.92 | 47.72±8.69 | Qingrelishi side | Low purine diet + meloxicam | 14 | 14 | 25 | 23 | 3 |
| Fang Zuo, | 58 | 30 | N/A | N/A | BaiHuGuiZhi | allopurinol | 14 | 14 | 52 | 22 | 1 |
| Yihui Yan, | 36 | 36 | N/A | N/A | BiNing Decoction | allopurinol | 28 | 28 | 33 | 28 | 1 |
| Xubin Zhao, | 25 | 25 | N/A | N/A | Blood-letting puncture and cupping+ Microwave therapy | Colchicine | 3~7 | 1~7 | 25 | 23 | 1 |
| Li Cheng, | 32 | 30 | N/A | N/A | Danghuiniantong | Meloxicam | 7 | 7 | 31 | 29 | 1 |
| Guicai Sun, | 65 | 65 | N/A | N/A | Compound xiqiancao capsule | Voltaren+ allopurinol | 21 | 21 | 58 | 54 | 1 |
| Yuhong Zhang, | 45 | 43 | N/A | N/A | Modified Sanmiao | Colchicine | 21 | 21 | 39 | 42 | 1 |
| Shengyun Wu, | 34 | 34 | 35.9±6.1 | 35.9±6.1 | Simiao Powder+ | Colchicine | 14 | 14 | 33 | 18 | 1 |
| Qingsheng He, | 50 | 50 | 34.5±4.7 | 32.7±3.2 | Modified Simiao | Colchicine | 7 | 7 | 49 | 44 | 3 |
| Lixin Wang, | 69 | 35 | N/A | N/A | Modified Simiao pill | Colchicine | N/A | N/A | 67 | 33 | 1 |
| Zhonghua Yang, | 60 | 30 | N/A | N/A | Jianpi qingrelishi | Colchicine | 15 | 15 | 55 | 27 | 1 |
| Wenping Cao, | 44 | 43 | N/A | N/A | JunHu analgesic | colchicine | 3 | 3 | 44 | 38 | 1 |
| Yanhong Zou, | 40 | 40 | N/A | N/A | Lizhuodingtong decoction | Nimesulide | 10 | 10 | 34 | 32 | 1 |
| Jincheng Cai, | 54 | 46 | N/A | N/A | Niantongxiaofeng prescription | colchicine | 15 | 15 | 52 | 43 | 1 |
| Wei Li, | 58 | 58 | N/A | N/A | Qingrechushi prescription | Etoricoxib Tablets | 14 | 14 | N/A | N/A | 3 |
| Yingxu Wang, | 33 | 31 | 46.97±9.65 | 41.16±9.72 | Discriminate treatment of Chinese medicine by clearing away heat and resolving turbid | Diclofenac Sodium Sustained Release | 31 | 31 | 31 | 27 | 1 |
| Wei Liu, 2016 | 36 | 35 | 46.73±16.25 | 47.06±15.82 | Compound Chinese medicine decoction of Clearing heat-toxin and eliminating dampness method | Diclofenac Sodium | 14 | 14 | 30 | 29 | 3 |
| Feng Yue, | 30 | 30 | N/A | N/A | Clearing heat-toxin and eliminating dampness method+ Gold paste(external) | colchicine | 7 | 7 | 30 | 30 | 1 |
| Yanming Ren, | 60 | 30 | N/A | N/A | Acid fat clear capsule | colchicine | 7 | 7 | 52 | 27 | 1 |
| Huilian Wang, | 40 | 40 | 48.4±12.8 | 49.1±13.1 | Gouty granule | Nimesulide | 10 | 10 | 34 | 33 | 1 |
| Wei Jin, | 32 | 32 | C | N/A | Self-prepared gout recipe+ Jiawei Jinhuang powder | colchicine | 7 | 7 | 30 | 24 | 1 |
| Hong Tu, | 30 | 30 | 44.9±9.1 | 45.1±8.1 | Gout clear granules | Diclofenac Sodium Sustained Release Tablets | 7 | 7 | 29 | 24 | 1 |
| Binchu Wang, | 52 | 38 | N/A | N/A | Gout decoction | Ibuprofen+ | 10 | 10 | 49 | 33 | 1 |
| Haifeng Li, | 73 | 80 | 45.6±10.1 | 47.2±12.4 | Xuanbi decoction | allopurinol | 30 | 30 | 67 | 69 | 1 |
| Hongtao Yan, | 20 | 20 | N/A | N/A | Xuanbi decoction | Indomethacin | 7 | 7 | 18 | 16 | 3 |
| Weigang Zeng, | 55 | 50 | N/A | N/A | Yushantongfeng decoction 2 | allopurinol | 7 | 7 | 54 | 32 | 1 |
| Weigang Zeng, | 120 | 116 | N/A | N/A | Yushantongfeng decoction | colchicine | N/A | N/A | 118 | 108 | 1 |
| Jiang Wu, | 36 | 36 | 51.34±6.28 | 52.46±7.4 | Acupuncture+Sanren decoction and Sijunzi decoction | Diclofenac Sodium Sustained Release Tablets | 7 | 7 | 33 | 30 | 1 |
| Jing Chen, | 61 | 55 | 52.1±1.2 | 51.5±1.4 | Chinese medicine and acupuncture | Colchicine+ | 7 | 7 | 58 | 47 | 1 |
| Minghai Zhou, | 20 | 20 | N/A | N/A | Simiao powder and acupuncture | Ibuprofen Sustained-release Capsules | 7 | 7 | 19 | 15 | 1 |
| Guangheng Cui, | 60 | 60 | N/A | N/A | Hoveniaacerbalindl | Meloxicam | 7 | 7 | 55 | 56 | 1 |
| Yangang Wang, | 35 | 35 | 45.0±6.5 | 46.0±5.7 | Compound decoction of Chinese herbal medicine | Colchicine+ allopurinol | 7 | 7 | N/A | N/A | 1 |
| Hai Lu, | 30 | 30 | N/A | N/A | Simiao pill and Gouty ointment | Allopurinol+ Sodium Bicarbonate | 7 | 7 | 29 | 25 | 2 |
| Bo Duan, | 54 | 54 | 40.26±10.98 | 42.31±11.77 | Oral administration of Chinese medicine decoction+Rebiqing granules(oral)+Chinese medicine(external) | Colchicine Tablets | 7 | 7 | 47 | 46 | 2 |
| Guoying Han, | 42 | 39 | N/A | N/A | Rabdosia rubescens, coix seed, Poria cocos, Shi Wei, Rhizoma Atractylodis, Cortex Phellodendri, Achyranthes bidentata, rhubarb, Eupatorium adenophorum | Allopurino+Celecoxib | 31 | 31 | 39 | 29 | 1 |
| Min Dai, | 39 | 39 | 35±2.5 | 35±2.5 | Atractylodes rhizome, Achyranthes bidentata, Smilax glabra, Cortex Phellodendri, honeysuckle vine, liquorice, 2corydalis tuber, astragalus root and coix seed | Diclofenac Sodium Sustained Release Tablets | 14 | 14 | 36 | 29 | 1 |
| Xiaohong He, | 28 | 26 | 42.5±7.7 | 46±11.8 | Simiao powder+Sihuang powder | Colchicine | 3 | 3 | 27 | 20 | 1 |
| Xiaoxia Wang, | 30 | 30 | 48.5±15.5 | 49.1±13.7 | Self-made prescription: Mountain arrowhead, clematis, peach, Atractylodes, Poria, Alisma, Adenophora, Polygonum cuspidatum, rice, Bixie | Colchicine | 10 | 10 | 28 | 29 | 1 |
| Huijuan Yao, | 56 | 54 | N/A | N/A | Modified | Colchicine | 10 | 10 | 51 | 52 | 1 |
| Lei Zhang, | 37 | 37 | 44.43±11.29 | 45.02±12.1 | Oral administration of Bixie decoction | Diclofenac Sodium Sustained Release Tablets | 7 | 7 | 33 | 31 | 1 |
| Bo Shi, | 45 | 40 | 49±16 | 48±14 | Clearing heat and dmp elimination tongluo | Colchicine | 10 | 10 | 38 | 25 | 1 |
| Liping Yan, | 38 | 31 | N/A | N/A | Clearing heat and dmp elimination prescription | Colchicine | 7 | 7 | 35 | 23 | 1 |
| Yulei Wu, | 38 | 38 | N/A | N/A | Clearing heat and removing dampness and activating blood circulation method | Sodium Bicarbonate Tablets+ Diclofenac Sodium Sustained Release Tablets | N/A | N/A | 38 | 32 | 1 |
| Yueqi Wang, | 32 | 32 | N/A | N/A | Chinese medicine of Clearing heat and removing dampness and activating blood circulation method | Diclofenac acid enteric coated tablets | 7 | 7 | 30 | 29 | 1 |
| Rong Li, | 75 | 75 | 50.24±12.37 | 49.15±13.06 | Bixieshenshi decoction and Taohongsiwu decoction | Celecoxib+ Sodium Bicarbonate Tablets | 10 | 10 | 69 | 62 | 1 |
| Shanshan Yu, | 40 | 40 | 48.2±8.6 | 46±9.7 | Dampness detoxification method | Nimesulide tablets | N/A | N/A | 38 | 34 | 1 |
| Weidong Qian, | 60 | 40 | N/A | N/A | Xitong Granule | Colchicine | 7 | 7 | 53 | 34 | 1 |
| Zheng Huang, | 32 | 30 | N/A | N/A | Qingrelishi Tongluo | Nimesulide tablets | 10 | 10 | 28 | 27 | 1 |
| Chongyu Tan, | 52 | 46 | N/A | N/A | Self-made Clearing heat and dmp elimination tongluo prescription | Colchicine+ Fenbid | 7 | 7 | 48 | 34 | 2 |
| Chun Kang, | 30 | 30 | 70.2±5.3 | 69.9±6.1 | Self-made Clearing heat and dmp elimination tongluo decoction | Ibuprofen Sustained-release Capsules+ | 7 | 7 | 28 | 24 | 2 |
| Xiaowu Fan, | 50 | 48 | N/A | N/A | Clearing heat and dmp elimination tongluo decoction | Fenbid | 7 | 7 | 48 | 38 | 2 |
| Jianchong Shen, | 61 | 61 | 45.78±7.45 | 46.47±8.35 | Laoshitongfeng prescription+acupuncture | Colchicine+ Sodium Bicarbonate Tablets | 7 | 7 | 57 | 49 | 1 |
| Guiqiong Huang, | 60 | 60 | 53.82±10.95 | 54.05±12.31 | Clearing heat and dmp elimination tongluo prescription | Colchicine | 7 | 7 | 55 | 38 | 1 |
| Xin Ouyang, | 30 | 30 | 57.77±6.62 | 56.37±6.74 | Bixiehuadu decoction | Butazolidin | 14 | 14 | 28 | 25 | 1 |
| Zhimin Qi, | 105 | 105 | 45.3±9.2 | 44.1±9.6 | Qingrelishi Zhuyu | Colchicine+ | 7 | 7 | 101 | 93 | 2 |
| Yaping Chen, | 45 | 43 | N/A | N/A | Clearing heat and dredging collaterals to clear turbid decoction | Diclofenac Sodium Sustained Release Tablets | 14 | 14 | 40 | 37 | 1 |
| Demei Li, | 40 | 40 | N/A | N/A | Clearing heat and dampness, blood stasis, relieving pain Tongluo Decoction; Qingre Tongluo releasing pain prescription | Colchicine+ Celecoxib Capsules+ Votalin(external) | 7 | 7 | 38 | 34 | 1 |
| Yanzhi Lin, | 30 | 30 | 53.55±10.67 | 55.73±11.92 | Self-made Sanjin decoction and Sanmiao powder | Colchicine+ | 30 | 30 | 28 | 22 | 2 |
| Dehe Li, | 40 | 36 | 44.3±5.2 | 43.1±4.5 | Shandayanhesimiao decoction | Colchicine | 14 | 14 | 36 | 26 | 1 |
| Jun Hao, | 30 | 30 | 46±8.03 | 45.16±7.97 | Gout mixture | Colchicine | 15 | 15 | 29 | 23 | 1 |
| Chongqing Yang, | 30 | 30 | N/A | N/A | Gout prescription | Votalin | 7 | 7 | 27 | 28 | 3 |
| Lin Wang, | 29 | 29 | N/A | N/A | Tongbi prescription | Diclofenac Sodium Sustained Release Tablets | 7 | 7 | 26 | 27 | 4 |
| Ayijiaman, | 56 | 44 | 44.3±4.3 | 44.9±3.9 | Tanrebi decoction | Sodium acetate | 14 | 14 | 54 | 37 | 1 |
| Chifeng Wang, | 36 | 36 | 51.7±3.2 | 52.1±2.9 | Simiao pill | Meloxicam | N/A | N/A | 33 | 30 | 1 |
| Jianping Luo, | 30 | 30 | N/A | N/A | Modified Simiao | Diclofenac Sodium Enteric-coated | 3 | 3 | N/A | N/A | 1 |
| Xianzhang Zeng, | 60 | 58 | N/A | N/A | Modified Simiao | Colchicine+ | 14 | 14 | 58 | 51 | 1 |
| Jinjin Jia, | 28 | 26 | 43±10.8 | 44±11.3 | Modified Simiao | Colchicine | 14 | 14 | 26 | 23 | 1 |
| Xiaozhong Yu, | 32 | 30 | N/A | N/A | Simiao powder | Ibuprofen+ Colchicine | 14 | 14 | 31 | 28 | 1 |
| Jinfeng Li, | 35 | 35 | N/A | N/A | Simiaomaqian powder | Diclofenac Sodium Sustained Release Tablets | 7 | 7 | 34 | 33 | 1 |
Outcome of the meta-analyses for the comparison between clearing heat and removing dampness method of Chinese traditional medicine and western medicine, according to study design.
| Author, year | Effective number | SUA | CRP | ESR | Adverse reactions | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| EG | CG | EG | CG | EG | CG | EG | CG | EG | CG | |
| Yan Zhang, 2016 | 25 | 23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fang Zuo, 2001 | 52 | 22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Yihui Yan, 2006 | 33 | 28 | 487.27± 98.88/374.88± 95.48 | 469.26± 114.41/414.52± 102.13 | N/A | N/A | N/A | N/A | N/A | N/A |
| Xubin Zhao, 2014 | 25 | 23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Li Cheng, 2009 | 31 | 29 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 9 |
| Guicai Sun, 2007 | 58 | 54 | 568.6±21.2/397.2±36.7 | 572.5±27.6/385.8±30.2 | N/A | N/A | 59.2±7.4/17.1±4.6 | 53.7±8.7/15±4.3 | N/A | N/A |
| Yuhong Zhang, 2003 | 39 | 42 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shengyun Wu, 2017 | 33 | 18 | N/A | N/A | 35.5±3.5/8.9±1.1 | 35.7±3.3/10.1±1.2 | 45.7±9.3/14.6±9.4 | 46.9±9.1/21.8±9.2 | N/A | N/A |
| Qingsheng He, 2016 | 49 | 44 | 511±47.77/370±21.56 | 497±50.12/476±19.57 | 31.34±9.12/8.04±1.29 | 29.77±8.9/9.26±2.55 | 45±11.26/17±6.78 | 47±12.57/21±5.91 | 0 | 5 |
| Lixin Wang, 2001 | 67 | 33 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 32 |
| Zhonghua Yang, 2007 | 55 | 27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Wenping Cao, 2008 | 44 | 38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Yanhong Zou, 2010 | 34 | 32 | 442.15±60.12/399.76±38.27 | 438.58±67.45/417.12±41.45 | 67.12±30.23/33.46±15.23 | 60.58±29.40 | 64.12±25.78/34.28±12.21 | 60.10±23.69/40.79±13.08 | N/A | N/A |
| Jincheng Cai, 2006 | 52 | 43 | 585±155/458±162 | 592±142/587±148 | N/A | N/A | N/A | N/A | N/A | N/A |
| Wei Li, 2016 | N/A | N/A | 536.24±54.16/316.49±48.28 | 529.75±52.67/376.62±35.39 | 32.94±5.84/13.26±8.49 | 33.18±5.63/20.17±9.64 | 24.21±9.64/10.26±5.35 | 23.68±9.71/14.86±5.47 | N/A | N/A |
| Yingxu Wang, 2014 | 31 | 27 | 605.21±132/474.63±85.4 | 601.16±114.2/454.51±92.2 | N/A | N/A | N/A | N/A | N/A | N/A |
| Wei Liu, 2016 | 30 | 29 | 548.25±96.31/394.34±32.69 | 541.45±48.11/46 | N/A | N/A | N/A | N/A | N/A | N/A |
| Feng Yue, 2005 | 30 | 30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Yanming Ren, 2007 | 52 | 27 | 544.36±86.27/341.25±79.34 | 567.74±91.13/387.32±64.64 | N/A | N/A | 52.61±12.35/28.37±9.36 | 48.22±11.79/42.72±0.24 | N/A | N/A |
| Huilian Wang, 2012 | 34 | 33 | N/A | N/A | 49.7±11.6/18.5±6.4 | 47.6±12.6/18.2±5.7 | 9.0±3.0/3.9±1.2 | 8.9±2.9/4.0±2.0 | N/A | 6 |
| Wei Jin, 2013 | 30 | 24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Hong Tu, 2015 | 29 | 24 | N/A | N/A | 26.28±7.89/5.47±3.01 | 24.16±6.99/12.12±4.21 | 39.62±16.51/14.71±8.97 | 37.74±14.63/24.07±12.61 | 1 | 5 |
| Binchu Wang, 2000 | 49 | 33 | 489±23.1/345±20.1 | 486±21.5/371±19.1 | N/A | N/A | N/A | N/A | N/A | N/A |
| Haifeng Li, 2012 | 67 | 69 | 287.6±56.4 | 426.1±89.2 | N/A | N/A | 21.1±5.4 | 38.3±10.0 | N/A | N/A |
| Hongtao Yan, 2006 | 18 | 16 | 537.85±39.72/425.3±16.24 | 558.5±31.27/550.8±25.09 | N/A | N/A | 45.30±7.97/40±5.39 | 44.55±8.11/43.95±5.85 | 1 | 8 |
| Weigang Zeng, 2010 | 54 | 32 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 2 |
| Weigang Zeng, 2007 | 118 | 108 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 60 |
| Jiang Wu, 2015 | 33 | 30 | 528.46±78.42/436.14±83.27 | 521.47±80.12/446.72±67.46 | 26.24±12.08/10.37±2.58 | 27.18±11.83/12.43±3.19 | 40.72±13.06/16.87±2.26 | 39.24±13.27/24.35±4.03 | 2 | 6 |
| Jing Chen, 2017 | 58 | 47 | 542.15±36.79/384.20±47.28 | 538.76±42.53/437.21±42.13 | N/A | N/A | N/A | N/A | N/A | N/A |
| Minghai Zhou, 2014 | 19 | 15 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 3 |
| Guangheng Cui, 2011 | 55 | 56 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Yangang Wang, 2005 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Hai Lu, 2013 | 29 | 25 | 564±80.5/326±20.3 | 518±75.4/349±34.7 | 36.1±4.3/14.6±5.6 | 34.2±6.8/18.4±3.9 | 65.7±18.5/22.6±7.3 | 63.4±11.7/29.6±6.9 | 2 | 1 |
| Bo Duan, 2016 | 47 | 46 | 673.31±25.26/421.43±58.90 | 666.42±31.54/432.27±70.11 | 36.83±9.62/15.42±8.94 | 34.56±10.11/17.02±7.78 | 20.52±9.98/8.23±5.83 | 18.95±10.01/8.99±6.37 | 19 | 24 |
| Guoying Han, 2010 | 39 | 29 | 568.6±92.5/412.5±94.7 | 581.7±102.4/483.4±107.6 | N/A | N/A | N/A | N/A | N/A | N/A |
| Min Dai, 2015 | 36 | 29 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Xiaohong He, 2008 | 27 | 20 | 508.0±63.6/276.1±23.2v | 512.2±57.6/408.3±30.9 | N/A | N/A | 56.5±10.2/17.4±5.7 | 54.9±11.5/30.6±8.3 | N/A | N/A |
| Xiaoxia Wang, 2010 | 28 | 29 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Huijuan Yao, 2010 | 51 | 52 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Lei Zhang, 2016 | 33 | 31 | 546.69±34.23/393.02±62.69 | 542.43±43.65/479.81±71.81 | N/A | N/A | 28.59±6.69/17.54±4.74 | 29.59±5.59/23.22±6.08 | 0 | 0 |
| Bo Shi, 2010 | 38 | 25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liping Yan, 2012 | 35 | 23 | 573.4±113.6/369.1±117.2 | 587.5±109.7/421.8±121.3 | N/A | N/A | N/A | N/A | N/A | N/A |
| Yulei Wu, 2015 | 38 | 32 | 573.7±102.9/428.5±122.5 | 582.7±112.5/368.4±117.8 | N/A | N/A | N/A | N/A | N/A | N/A |
| Yueqi Wang, 2013 | 30 | 29 | 542.36±54.55/351.12±43.92 | 534.99±58.81/424.73±56.79 | 30.90±10.15/6.70±5.11 | 31.45±10.75/12.65±5.26 | 28.90±6.53/6.74±3.14 | 29.45±11.58/7.67±4.11 | 0 | 7 |
| Rong Li, 2014 | 69 | 62 | 525.68±114.85/308.30±50.96 | 537.01±126.46/375.60±61.17 | N/A | N/A | N/A | N/A | N/A | N/A |
| Shanshan Yu, 2008 | 38 | 34 | 552.80±92.76/284.43±58.39 | 560.48±89.37/363.22±63.21 | N/A | N/A | N/A | N/A | 1 | 11 |
| Weidong Qian, 2007 | 53 | 34 | N/A | N/A | N/A | N/A | N/A | N/A | 1 | 5 |
| Zheng Huang, 2013 | 28 | 27 | 477.16±97.33/430.65±88.97 | 465.52±90.13/451.91±89.48 | N/A | N/A | N/A | N/A | N/A | N/A |
| Chongyu Tan, 2013 | 48 | 34 | 568.73±38.29/326.81±38.14 | 573.77±39.87/371.90±38.39 | N/A | N/A | N/A | N/A | 4 | 16 |
| Chun Kang, 2012 | 28 | 24 | 485.65±53.11/303.22±46.35 | 489.18±52.61/396.43±41.91 | N/A | N/A | N/A | N/A | 1 | 9 |
| Xiaowu Fan, 2013 | 48 | 38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Jianchong Shen, 2014 | 57 | 49 | 495.99±50.73/312.78±54.03 | 485.50±47.58/378.07±50.89 | N/A | N/A | N/A | N/A | 1 | 5 |
| Guiqiong Huang, 2016 | 55 | 38 | 547.48±50.93/304.28±60.14 | 546.37±46.65/415.96±51.86 | 26.17±10.28/5.98±1.45 | 25.94±9.45/16.05±1.76 | 35.18±8.82/15.79±4.21 | 34.95±7.88/23.57±4.52 | N/A | 17 |
| Xin Ouyang, 2004 | 28 | 25 | 492.54±76.03/287.53±93.04 | 498.00±83.46/367.53±93.81 | N/A | N/A | 54.65±11.78/23.43±16.71 | 53.10±10.82/32.03±17.42 | 0 | 18 |
| Zhimin Qi, 2016 | 101 | 93 | 515.13±118.04/318.57±76.12 | 508.67±121.38/392.06±78.39 | 24.60±7.68/8.82±2.58 | 23.86±7.44/12.26±2.71 | 48.91±12.68/17.58±5.22 | 48.36±12.27/22.14±6.15 | 4 | 16 |
| Yaping Chen, 2014 | 40 | 37 | N/A | N/A | N/A | N/A | N/A | N/A | 15 | 32 |
| Demei Li, 2012 | 38 | 34 | 496±66.9/266±48.6 | 498±49.6/562±51.6 | 35.4±6.5/15.6±5.2 | 38.5±7.8/21.9±6.1 | 68.3±15.6/21.5±12.5 | 64.9±12.6/30.2±7.9 | 5 | 16 |
| Yanzhi Lin, 2009 | 28 | 22 | 506.57±119.90/352.41±79.93 | 548.70±83.98/402.42±85.53 | 8.15±1.25/4.64±0.97 | 8.52±1.23/6.32±1.09 | 32.62±13.82/17.9±5.2 | 32.40±13.93/26.4±10.87 | N/A | 17 |
| Dehe Li, 2007 | 36 | 26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Jun Hao, 2014 | 29 | 23 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 11 |
| Chongqing Yang, 2006 | 27 | 28 | 487.27±98.87/404.88±95.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Lin Wang, 2011 | 26 | 27 | 498.33±87.25/491.13±86.89 | 498.28±128.18/482.23±116.51 | 29.94±22.06/9.24±5.7 | 52.46±56.82/18.16±28.10 | N/A | N/A | 0 | 1 |
| Ayijiaman, 2012 | 54 | 37 | 539.16±34.49/376.3±52.85 | 552.29±46.15/425.79±48.69 | N/A | N/A | N/A | N/A | N/A | N/A |
| Chifeng Wang, 2014 | 33 | 30 | 482.5±51.3/388.3±50.4 | 481.5±50.9/420.2±55.9 | 24.4±3.6/15±2.6 | 24.34±3.7/16±2.9 | 26.3±4.3/13.6±7.2 | 26.2±4.5/15.8±6.8 | N/A | N/A |
| Jianping Luo, 2010 | N/A | N/A | 545.1±5.1/501.2±5.2 | 546.9±4.9/518.1±5 | N/A | N/A | N/A | N/A | N/A | N/A |
| Xianzhang Zeng, 2013 | 58 | 51 | 589.35±92.87/317.26±89.23 | 578.34±95.31/323.44±92.59 | N/A | N/A | N/A | N/A | N/A | N/A |
| Jinjin Jia, 2010 | 26 | 23 | 488.3±78.4/285.75±75.6 | 490.2±72.5/433.5±77.5 | N/A | N/A | N/A | N/A | 0 | 5 |
| Xiaozhong Yu, 2013 | 31 | 28 | 556±23.1/216.12.6 | 552.±21.8/221±15.2 | N/A | N/A | N/A | N/A | 1 | 15 |
| Jinfeng Li, 2013 | 34 | 33 | 468.39±100.28/342.47±90.26 | 452.28±98.75/437.65±94.57 | N/A | N/A | N/A | N/A | N/A | N/A |
aEG: experimental group, CG: control group; bSUA: serum uric acid; cCRP: C-reactive protein; dESR: Erythrocyte Sedimentation Rate; eN/A: not applicable.
Figure 2Risk of bias summary.
Figure 3Risk of bias graph.
Figure 4An analysis of the adverse reactions caused by clearing heat and removing dampness method and western medicine in the treatment of gout.
Figure 5An analysis of the effective of clearing heat and removing dampness method and western medicine in the treatment of gout.
Figure 6Effects of clearing heat and removing dampness method and western medicine on serum uric acid in the treatment of gout.
Figure 7Effects of clearing heat and removing dampness method and western medicine on C-reactive protein in the treatment of gout.
Figure 8Effects of clearing heat and removing dampness method and western medicine on ESR in the treatment of gout.